focus -WSS

focus

author：Wikipedia 2025-09-06 06:04:04 - browse：86448

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Health insurers' Q3 question: how much care are people getting?

WSS

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Some top drug companies are starting to take action on climate

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

focus

focus

leisure time

Jerome Adams on the need for new antivirals for Covid

The stability of $0 premiums in Medicare Advantage

Apple is now the first public company to be valued at $3 trillion

NYC plans to house migrants on an island in the East River

Virginia high school admissions case could be legal follow

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Affirmative action in medical school literally saved lives

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Drug repurposing or repositioning? The language matters

'The Exorcist' director William Friedkin dead at 87

focus

New oral drug delivery patch is modeled after octopus tentacles

With Roe v Wade overturned, abortion providers work to adapt

Biden will tout long

CRISPR base editing slashes cholesterol levels in monkeys

Stop Congress from blocking public access to science

Will an HIV vaccine ever be a reality?

leisure time

leisure time

focus

explore